These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8316903)

  • 1. [Analysis of the state of patients with rheumatoid arthritis using a personal computer].
    Hirohata S; Kawashima C; Shinohara S; Sawada T; Nishioka Y; Tohma S; Kisaki T; Inoue T; Iwamoto S; Ito K
    Ryumachi; 1993 Apr; 33(2):131-41. PubMed ID: 8316903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group.
    Terkeltaub R; Esdaile J; Décary F; Tannenbaum H
    J Rheumatol; 1983 Jun; 10(3):418-24. PubMed ID: 6411919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study.
    Beyeler C; Banks R; Thompson D; Forbes MA; Cooper EH; Bird HA
    J Rheumatol; 1996 Feb; 23(2):241-4. PubMed ID: 8882026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine-induced increase in intracellular glutathione correlating to clinical response in rheumatoid arthritis.
    Munthe E; Kåss E; Jellum E
    J Rheumatol Suppl; 1981; 7():14-9. PubMed ID: 6785436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
    Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E; Kåss E
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranous glomerulonephritis in patients with rheumatoid arthritis.
    Yoshida A; Morozumi K; Takeda A; Koyama K; Oikawa T
    Clin Ther; 1994; 16(6):1000-6. PubMed ID: 7697679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
    Minami M; Kaneda K
    Ryumachi; 1995 Oct; 35(5):780-91. PubMed ID: 8594657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
    Nagashima M; Asano G; Yoshino S
    J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
    Amasaki Y; Sagawa A; Atsumi T; Jodo S; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S; Kobayashi H
    Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Yellow nail syndrome" and rheumatoid arthritis.
    Ichikawa Y; Shimizu H; Arimori S
    Tokai J Exp Clin Med; 1991 Dec; 16(5-6):203-9. PubMed ID: 1820660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis.
    Sambrook PN; Browne CD; Champion GD; Day RO; Vallance JB; Warwick N
    J Rheumatol; 1982; 9(6):932-4. PubMed ID: 6819360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
    Genevay S; Finckh A; Ciurea A; Chamot AM; Kyburz D; Gabay C;
    Arthritis Rheum; 2007 May; 57(4):679-85. PubMed ID: 17471545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.